Last reviewed · How we verify

Polio Sabin

GlaxoSmithKline · Phase 3 active Biologic

The Polio Sabin vaccine works by introducing a weakened form of the poliovirus to stimulate an immune response.

The Polio Sabin vaccine works by introducing a weakened form of the poliovirus to stimulate an immune response. Used for Polio prevention.

At a glance

Generic namePolio Sabin
Also known asOPV, Oral Polio vaccine (OPV).
SponsorGlaxoSmithKline
ModalityBiologic
Therapeutic areaInfectious Diseases
PhasePhase 3

Mechanism of action

This immune response helps the body recognize and fight the poliovirus, providing protection against polio infection. The vaccine is administered orally and contains three different strains of the weakened poliovirus.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results